Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
Clinical trial NCT00935831 · COMPLETED
Trial details
- NCT number
- NCT00935831
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-12
- Primary completion
- 2010-04-27
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.